131 related articles for article (PubMed ID: 11007965)
1. AMP-activated protein kinase counteracted the inhibitory effect of glucose on the phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes.
Hubert A; Husson A; Chédeville A; Lavoinne A
FEBS Lett; 2000 Sep; 481(3):209-12. PubMed ID: 11007965
[TBL] [Abstract][Full Text] [Related]
2. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase.
Lochhead PA; Salt IP; Walker KS; Hardie DG; Sutherland C
Diabetes; 2000 Jun; 49(6):896-903. PubMed ID: 10866040
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of glucose on phosphoenolpyruvate carboxykinase gene expression in cultured hepatocytes is transcriptional and requires glucose metabolism.
Cournarie F; Azzout-Marniche D; Foretz M; Guichard C; Ferre P; Foufelle F
FEBS Lett; 1999 Nov; 460(3):527-32. PubMed ID: 10556529
[TBL] [Abstract][Full Text] [Related]
4. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
5. The 5'-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex.
Leclerc I; Kahn A; Doiron B
FEBS Lett; 1998 Jul; 431(2):180-4. PubMed ID: 9708898
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.
Leclerc I; Lenzner C; Gourdon L; Vaulont S; Kahn A; Viollet B
Diabetes; 2001 Jul; 50(7):1515-21. PubMed ID: 11423471
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase in metabolic control and insulin signaling.
Towler MC; Hardie DG
Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
[TBL] [Abstract][Full Text] [Related]
9. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
Corton JM; Gillespie JG; Hawley SA; Hardie DG
Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
[TBL] [Abstract][Full Text] [Related]
10. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase.
Bronner M; Hertz R; Bar-Tana J
Biochem J; 2004 Dec; 384(Pt 2):295-305. PubMed ID: 15312046
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuning insulin and nitric oxide signalling by turning up the AMPs: new insights into AMP-activated protein kinase signalling.
Long YC; Zierath JR
Diabetologia; 2005 Dec; 48(12):2451-3. PubMed ID: 16283241
[No Abstract] [Full Text] [Related]
12. AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.
Salt IP; Johnson G; Ashcroft SJ; Hardie DG
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):533-9. PubMed ID: 9794792
[TBL] [Abstract][Full Text] [Related]
13. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase.
Zheng D; MacLean PS; Pohnert SC; Knight JB; Olson AL; Winder WW; Dohm GL
J Appl Physiol (1985); 2001 Sep; 91(3):1073-83. PubMed ID: 11509501
[TBL] [Abstract][Full Text] [Related]
14. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle.
Stoppani J; Hildebrandt AL; Sakamoto K; Cameron-Smith D; Goodyear LJ; Neufer PD
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1239-48. PubMed ID: 12388122
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase.
Berasi SP; Huard C; Li D; Shih HH; Sun Y; Zhong W; Paulsen JE; Brown EL; Gimeno RE; Martinez RV
J Biol Chem; 2006 Sep; 281(37):27167-77. PubMed ID: 16849326
[TBL] [Abstract][Full Text] [Related]
17. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
[TBL] [Abstract][Full Text] [Related]
19. A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes.
Downs SM; Hudson ER; Hardie DG
Dev Biol; 2002 May; 245(1):200-12. PubMed ID: 11969266
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
